NLM Logo

PAVE protocol 2 MeSH Supplementary Concept Data 2024


MeSH Supplementary
PAVE protocol 2
Unique ID
C066096
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C066096
Entry Term(s)
CODE protocol
T-CODE protocol
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Doxorubicin
Etoposide
Vincristine
Frequency
29
Note
chemotherapy protocol consisting of above compounds; used in the therapy of breast & lung cancer
Source
Gan To Kagaku Ryoho 1990;17(10):2005
Date of Entry
1990/11/16
Revision Date
2000/11/30
PAVE protocol 2 Preferred
T-CODE protocol Related
CODE protocol Related
page delivered in 0.005s